TY - JOUR A1 - Prelog, Martina A1 - Almanzar, Giovanni A1 - Eberle, Gernot A1 - Lassacher, Andrea A1 - Specht, Christian A1 - Koppelstaetter, Christian A1 - Heinz-Erian, Peter A1 - Trawöger, Rudolf A1 - Bernhard, David T1 - Maternal cigarette smoking and its effect on neonatal lymphocyte subpopulations and replication JF - BMC Pediatrics N2 - Background Significant immunomodulatory effects have been described as result of cigarette smoking in adults and pregnant women. However, the effect of cigarette smoking during pregnancy on the lymphocyte subpopulations in newborns has been discussed, controversially. Methods In a prospective birth cohort, we analyzed the peripheral lymphocyte subpopulations of smoking (SM) and non-smoking mothers (NSM) and their newborns and the replicative history of neonatal, mostly naive CD4 + CD45RA + T cells by measurements of T-cell-receptor-excision-circles (TRECs), relative telomere lengths (RTL) and the serum cytokine concentrations. Results SM had higher lymphocyte counts than NSM. Comparing SM and NSM and SM newborns with NSM newborns, no significant differences in proportions of lymphocyte subpopulations were seen. Regardless of their smoking habits, mothers had significantly lower naive T cells and higher memory and effector T cells than newborns. NSM had significantly lower percentages of CD4 + CD25++ T cells compared to their newborns, which was not significant in SM. There were no differences regarding cytokine concentrations in newborns of SM and NSM. However, NSM had significantly higher Interleukin-7 concentrations than their newborns. Regardless of smoking habits of mothers, newborns had significantly longer telomeres and higher TRECs than their mothers. Newborns of SM had significantly longer telomeres than newborns of NSM. Conclusions Apart from higher lymphocyte counts in SM, our results did not reveal differences between lymphocyte subpopulations of SM and NSM and their newborns, respectively. Our finding of significantly longer RTL in newborns of SM may reflect potential harm on lymphocytes, such as cytogenetic damage induced by smoking. KW - Cigarette smoking KW - Lymphocytes KW - T cell receptor excision circles KW - Telomeres Y1 - 2013 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-96435 UR - http://www.biomedcentral.com/1471-2431/13/57 ER - TY - JOUR A1 - Thong, Melissa S. Y. A1 - Doege, Daniela A1 - Weißer, Linda A1 - Koch-Gallenkamp, Lena A1 - Jansen, Lina A1 - Bertram, Heike A1 - Eberle, Andrea A1 - Holleczek, Bernd A1 - Nennecke, Alice A1 - Waldmann, Annika A1 - Zeissig, Sylke Ruth A1 - Brenner, Hermann A1 - Arndt, Volker T1 - Persisting deficits in health-related quality of life of colorectal cancer survivors 14–24 years post-diagnosis: a population-based study JF - Current Oncology N2 - (1) Background: The health-related quality of life (HRQOL) of colorectal cancer (CRC) survivors >10 years post-diagnosis is understudied. We aimed to compare the HRQOL of CRC survivors 14–24 years post-diagnosis to that of age- and sex-matched non-cancer controls, stratified by demographic and clinical factors. (2) Methods: We used data from 506 long-term CRC survivors and 1489 controls recruited from German population-based multi-regional studies. HRQOL was assessed with the European Organization for Research and Treatment of Cancer Quality of Life Core-30 (EORTC QLQ-C30) questionnaire. We estimated differences in the HRQOL of CRC survivors and controls with multiple regression, adjusted for age at survey, sex, and education, where appropriate. (3) Results: CRC survivors reported poorer social functioning but better health status/QOL than controls. CRC survivors, in general, had higher levels of symptom burden, and in particular diarrhea and constipation, regardless of demographic or clinical factors. In stratified analyses, HRQOL differed by age, sex, cancer type, and having a permanent stoma. (4) Conclusions: Although CRC survivors may have a comparable health status/QOL to controls 14–24 years after diagnosis, they still live with persistent bowel dysfunction that can negatively impact aspects of functioning. Healthcare providers should provide timely and adapted follow-up care to ameliorate potential long-term suffering. KW - colorectal cancer KW - long-term survivors KW - health-related quality of life KW - population-based KW - non-cancer controls Y1 - 2023 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-311084 SN - 1718-7729 VL - 30 IS - 3 SP - 3373 EP - 3390 ER -